Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs.
Julie BarberioTimothy L LashAjay K NookaAshley I NaimiRachel E PatzerChristopher Kim
Published in: Acta haematologica (2024)
Results suggest that sequential exposure to IMiDs is a risk factor for higher grade cytopenias. These findings have profound clinical implications in choosing newer LOTs with potential risks of cytopenia.